SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-003299
Filing Date
2020-02-05
Accepted
2020-02-05 17:01:09
Documents
1
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3708
  Complete submission text file 0000899243-20-003299.txt   5051
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address T2 BIOSYSTEMS, INC. 101 HARTWELL AVE LEXINGTON MA 02421
Business Address
McDonough John (Reporting) CIK: 0001615937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36571 | Film No.: 20579604